| Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline G Raghu, M Remy-Jardin, JL Myers, L Richeldi, CJ Ryerson, DJ Lederer, ... American journal of respiratory and critical care medicine 198 (5), e44-e68, 2018 | 3200 | 2018 |
| Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ... American journal of respiratory and critical care medicine 194 (3), 265-275, 2016 | 1263 | 2016 |
| Pulmonary Fibrosis and COVID-19: the potential role for antifibrotic therapy RG George, Peter: Wells, Athol: Jenkins Lancet Respiratory Medicine, 2020 | 1079 | 2020 |
| Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ... Annals of the American Thoracic Society 16 (1), 22-28, 2019 | 622 | 2019 |
| The rising incidence of idiopathic pulmonary fibrosis in the UK V Navaratnam, KM Fleming, J West, CJP Smith, RG Jenkins, A Fogarty, ... Thorax 66 (6), 462-467, 2011 | 556 | 2011 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 500 | 2021 |
| Respiratory follow-up of patients with COVID-19 pneumonia PM George, SL Barratt, R Condliffe, SR Desai, A Devaraj, I Forrest, ... Thorax 75 (11), 1009-1016, 2020 | 434 | 2020 |
| The role of proteases in transforming growth factor-β activation G Jenkins The international journal of biochemistry & cell biology 40 (6-7), 1068-1078, 2008 | 417 | 2008 |
| Ligation of protease-activated receptor 1 enhances αv β6 integrin–dependent TGF-β activation and promotes acute lung injury RG Jenkins, X Su, G Su, CJ Scotton, E Camerer, GJ Laurent, GE Davis, ... The Journal of clinical investigation 116 (6), 1606-1614, 2006 | 381 | 2006 |
| The pathogenesis of idiopathic pulmonary fibrosis WR Coward, G Saini, G Jenkins Therapeutic Advances in Respiratory Disease 4 (6), 367-388, 2010 | 343 | 2010 |
| Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study RG Jenkins, JK Simpson, G Saini, JH Bentley, AM Russell, R Braybrooke, ... The lancet Respiratory medicine 3 (6), 462-472, 2015 | 310 | 2015 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 309 | 2022 |
| An Official American Thoracic Society Workshop Report: Use of Animal Models for the Preclinical Assessment of Potential Therapies for Pulmonary Fibrosis. WES Jenkins RG, Moore BB, Chambers RC, Eickelberg O, Königshoff M, Kolb M ... Am J Resp Cell Mol Biol 56 (5), 667-679, 2017 | 308 | 2017 |
| Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin … CB Keerthisingam, RG Jenkins, NK Harrison, NA Hernandez-Rodriguez, ... The American journal of pathology 158 (4), 1411-1422, 2001 | 281 | 2001 |
| TGF-β activation and lung fibrosis AL Tatler, G Jenkins Proceedings of the American Thoracic Society 9 (3), 130-136, 2012 | 275 | 2012 |
| Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study RJ Allen, J Porte, R Braybrooke, C Flores, TE Fingerlin, JM Oldham, ... The Lancet respiratory medicine 5 (11), 869-880, 2017 | 270 | 2017 |
| Emerging therapeutic opportunities for integrin inhibitors RJ Slack, SJF Macdonald, JA Roper, RG Jenkins, RJD Hatley Nature Reviews Drug Discovery 21 (1), 60-78, 2022 | 258 | 2022 |
| Genome-wide association study of susceptibility to idiopathic pulmonary fibrosis RJ Allen, B Guillen-Guio, JM Oldham, SF Ma, A Dressen, ML Paynton, ... American journal of respiratory and critical care medicine 201 (5), 564-574, 2020 | 257 | 2020 |
| Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq MY Xu, J Porte, AJ Knox, PH Weinreb, TM Maher, SM Violette, ... The American journal of pathology 174 (4), 1264, 2009 | 246 | 2009 |
| An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study TM Maher, E Oballa, JK Simpson, J Porte, A Habgood, WA Fahy, A Flynn, ... The Lancet Respiratory Medicine 5 (12), 946-955, 2017 | 231 | 2017 |
